Angus C. Russell
Chairman of the Board
Angus Russell has served as Chairman of the Board since March 2014. A veteran in the global biopharmaceutical industry with more than 30 years’ experience in commercial execution, operations, and strategic acquisitions, he has served on the Board of Directors of Mallinckrodt since August 2014, BioTime, Inc. since December 2014, and TherapeuticsMD, Inc. since March 2015. Mr. Russell also served as a Director at Shire Plc from 1999 to 2013. During his tenure at Shire Plc, Mr. Russell served as CEO from 2008 to 2013 and CFO from 1999 to 2008. While CEO at Shire, Mr. Russell was also the Chair of Shire’s Leadership Team and a lead member of the Shire Management Committee, which designed and implemented the company’s immensely successful long-term business strategy. Prior to joining Shire, Mr. Russell served at ICI, Zeneca, and AstraZeneca in various senior positions, including VP of Corporate Finance at AstraZeneca.